Funding Details
- Awarder
- Inbox
- Date Award
- May 18, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Founding Year
- 2019
- Traction
- Eikon has raised a total of $1.1bn since its founding, with significant funding rounds including $106m in Series C in 2023.
- Founders
- Eric Betzig
- Company Description
- Eikon Therapeutics is a US-based biotech company focused on advancing its portfolio of cancer candidates, including EIK1001, a TLR7/8 agonist currently in Phase III trials for melanoma.
- Market
- Cancer therapeutics
- Location
-
United States
- Coinvestors
- Lux Capital, Alexandria Venture Investments, AME Cloud Ventures, The Column Group, E15 VC, Foresite Capital, General Catalyst, Soros Capital
Links